SlowBull
The Business Brief FRIDAY, 4 SEPTEMBER 2026
← All stories
Markets

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

1 source ·1 article ·4h ago

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.

Covered by 1 outlet

Biopharmadive 1

All coverage · 1 article

BioPharma Dive ·4h ago

Ionis’ rare neurology drug approved; Pfizer inks an ADC deal

Zanvastro is now the first approved medicine for Alexander disease. Elsewhere, an immune system specialist posted positive results and a cell therapy developer turned to layoffs.